Showing results (1541-1550 of 6,130) with videos related to
Sort By:
Pageof 613
International Journal of Antimicrobial Agents|April 13, 2016
Dictyostelium discoideum as a surrogate host-microbe model for antivirulence screening in Pseudomonas aeruginosa PAO1Catalina Bravo-Toncio, Javiera A Álvarez, Francisca Campos, et al.International Journal of Antimicrobial Agents|August 13, 2016
Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicityAnastasija Reimer, Florian Seufert, Matthias Weiwad, et al.International Journal of Antimicrobial Agents|February 8, 2025
Transgenerational gut dysbiosis: Unveiling the dynamics of antibiotic resistance through mobile genetic elements from mothers to infantsSamiya Farooq, Absar Talat, Achal Dhariwal, et al.International Journal of Antimicrobial Agents|February 8, 2025
Development and validation of a time-varying correction factor for QT interval assessment in drug-resistant tuberculosis patientsThanakorn Vongjarudech, Anne-Gaëlle Dosne, Bart Remmerie, et al.International Journal of Antimicrobial Agents|February 2, 2025
Evaluation of in vitro pharmacodynamic drug interactions of ceftazidime-avibactam with tigecycline in ESBL- and carbapenemase producing Escherichia coli and Klebsiella pneumoniaeAneeq Farooq, Bernhard Drotleff, Niklas Kroemer, et al.International Journal of Antimicrobial Agents|February 2, 2025
Antibiotic shortages: An overview by the alliance for the prudent use of antibiotics (APUA)Fatima Allaw, Huong Vu Thi Lan, Miki Nagao, et al.International Journal of Antimicrobial Agents|February 1, 2025
In vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates collected from two general hospitals in SingaporeZhong Yang, Tze-Peng Lim, Nurhayati Binte Mohamed Yusoff, et al.International Journal of Antimicrobial Agents|January 18, 2025
Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort studyAbdullah Tarık Aslan, Emre Kara, Gamze Köksal, et al.International Journal of Antimicrobial Agents|January 10, 2025
An integrative and translational PK/PD modelling approach to explore the combined effect of polymyxin B and minocycline against Klebsiella pneumoniaeChenyan Zhao, Sanne van den Berg, Zhigang Wang, et al.International Journal of Antimicrobial Agents|January 8, 2025
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysisSalma M Bahnasawy, Hifza Ahmed, Markus Zeitlinger, et al.Pageof 613